In vitro anti-human immunodeficiency virus (HIV) activity of XM323, a novel HIV protease inhibitor.

Ähnliche Einträge

• In vitro isolation and identification of human immunodeficiency virus (HIV) variants with reduced sensitivity to C-2 symmetrical inhibitors of HIV type 1 protease.
  von: Otto, M J, et al.
  Veröffentlicht: (1993)
• DMP 323, a nonpeptide cyclic urea inhibitor of human immunodeficiency virus (HIV) protease, specifically and persistently blocks intracellular processing of HIV gag polyprotein.
  von: Rayner, M M, et al.
  Veröffentlicht: (1994)
• In vitro anti-human immunodeficiency virus (HIV) activities of transition state mimetic HIV protease inhibitors containing allophenylnorstatine.
  von: Kageyama, S, et al.
  Veröffentlicht: (1993)
• Crystal structure of human immunodeficiency virus (HIV) type 2 protease in complex with a reduced amide inhibitor and comparison with HIV-1 protease structures.
  von: Tong, L, et al.
  Veröffentlicht: (1993)
• Combinative interactions of a human immunodeficiency virus (HIV) Tat antagonist with HIV reverse transcriptase inhibitors and an HIV protease inhibitor.
  von: Connell, E V, et al.
  Veröffentlicht: (1994)